Browsing Tag
neuroinflammation
3 posts
Why industry observers are watching Tenvie Therapeutics’ TNV262 biomarker readout in 2026
Tenvie Therapeutics’ TNV262 readout in 2026 could reshape obesity and cardiometabolic drug development. Read why markets are watching closely.
Tiziana Life Sciences strengthens intranasal foralumab development with Renaissance Lakewood partnership
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA), a clinical-stage biotechnology company focused on immunomodulation therapies, has announced a strategic…
InMed Pharmaceuticals’ INM-901 shows breakthrough potential in Alzheimer’s disease treatment
In a significant development in Alzheimer’s disease research, InMed Pharmaceuticals Inc., a biotechnology company specialising in the development…